Univariate | Multivariate | |||
---|---|---|---|---|
Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
Age (y) > 70 | 0.90 (0.60–1.35) | 0.617 | ||
PS ≥ 1 | 1.04 (0.69–1.56) | 0.864 | ||
GS ≥ 9 | 1.00 (0.65–1.53) | 0.982 | ||
PSA (ng/ml) > 100 | 0.93 (0.62–1.41) | 0.743 | ||
Hb (g/dl) < 12 | 1.245 (0.828–1.871) | 0.292 | ||
LDH (U/L) > 300 | 1.28 (0.81–2.02) | 0.298 | ||
ALP (U/L) > 350 | 0.93 (0.62–1.40) | 0.739 | ||
Bone meta at diagnosis | 1.55 (1.03–2.34) | 0.037* | 1.03 (1.03–2.37) | 0.037* |
Time to CRPC (y) < 1 | 1.19 (0.79–1.79) | 0.4 | ||
DTX cycle< 10 | 1.40 (0.92–2.13) | 0.121 | ||
ABI or ENZA | 0.73 (0.45–1.17) | 0.184 | ||
Low initial CBZ dose | 1.03 (0.67–1.58) | 0.905 | 0.95 (0.62–1.47) | 0.832 |
RDI 60% or lower | 0.86 (0.54–1.39) | 0.545 |